|
General Information
|
|
|
Product
|
SARS-CoV-2 Nucleocapsid Protein Antibody FITC
|
|
Description
|
FITC-Conjugated Severe acute respiratory syndrome Coronavirus 2 N protein Antibody
|
|
Verified Applications
|
ELISA, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Virus
|
|
Immunogen
|
Synthetic peptide taken from unique amino acid sequence on nucleocapsid phosphoprotein [severe acute respiratory syndrome coronavirus 2].
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.5-1.5 µg/µl in antibody stabilization buffer
|
|
Immunoglobulin
|
IgG
|
|
Form
|
FITC-Conjugated
|
|
Purification Method
|
Immobilized antigen affinity chromatography
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
ELISA
|
1:50,000
|
|
Immunoprecipitation
|
1:200
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Alternative Nomenclature
|
N Structural Protein
Nucleocapsid phosphoprotein
Severe acute respiratory syndrome Coronavirus 2 Wuhang Seafood market Pneumonia virus isolate Wuhan-Hu-1
WUHAN-N Antibody
|
| |
|
SARS-CoV-2 Nucleocapsid Protein Antibody
SARS-CoV-2 Nucleocapsid Protein Antibody BIOTIN
COVID19 N Protein, Nucleocapsid Blocking Peptide
SARS-CoV-2 Nucleocapsid Positive Control
